Evidence map›Paper›PMID 37601355›Full record

ArticleFrontiers in microbiology2023

High seroprevalence of Leishmania infantum is linked to immune activation in people with HIV: a two-stage cross-sectional study in Bahia, Brazil.

Laise de Moraes, Luciane Amorim Santos, Liã Bárbara Arruda, Maria da Purificação Pereira da Silva, Márcio de Oliveira Silva, José Adriano Góes Silva, André Ramos, Marcos Bastos Dos Santos, Felipe Guimarães Torres, Cibele Orge and 17 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Assessment of asymptomaticFrontiers in medicine · 2025
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 8 institutions in 5 countries.

Laise de MoraesPrograma de Pós-graduação em Ciências da Saúde, Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.
Luciane Amorim SantosPrograma de Pós-graduação em Ciências da Saúde, Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.
Liã Bárbara ArrudaCentre for Clinical Microbiology, Division of Infection & Immunity, University College London, London, United Kingdom.
Maria da Purificação Pereira da SilvaCentro Estadual Especializado em Diagnóstico, Assistência e Pesquisa, Secretaria de Saúde do Estado da Bahia, Salvador, Brazil.
Márcio de Oliveira SilvaCentro Estadual Especializado em Diagnóstico, Assistência e Pesquisa, Secretaria de Saúde do Estado da Bahia, Salvador, Brazil.
José Adriano Góes SilvaPrograma de Pós-graduação em Ciências da Saúde, Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.
André RamosCentro Estadual Especializado em Diagnóstico, Assistência e Pesquisa, Secretaria de Saúde do Estado da Bahia, Salvador, Brazil.
Marcos Bastos Dos SantosInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Felipe Guimarães TorresInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Cibele OrgeInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Antonio Marcos Dos Santos TeixeiraInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Thiago Santos VieiraInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Laura RamírezDepartamento de Biología Molecular, Facultad de Ciencias, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Madrid, Spain.
Manuel SotoDepartamento de Biología Molecular, Facultad de Ciencias, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Madrid, Spain.
Maria Fernanda Rios GrassiInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Isadora Cristina de SiqueiraInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Dorcas Lamounier CostaLaboratório de Leishmanioses, Instituto de Doenças Tropicais Natan Portella, Universidade Federal do Piauí, Teresina, Brazil.
Carlos Henrique Nery CostaLaboratório de Leishmanioses, Instituto de Doenças Tropicais Natan Portella, Universidade Federal do Piauí, Teresina, Brazil.
Bruno de Bezerril AndradeInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Kevan AkramiPrograma de Pós-graduação em Ciências da Saúde, Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.
Camila Indiani de OliveiraPrograma de Pós-graduação em Ciências da Saúde, Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.
Viviane Sampaio BoaventuraPrograma de Pós-graduação em Ciências da Saúde, Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.
Manoel Barral-NettoPrograma de Pós-graduação em Ciências da Saúde, Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.
Aldina BarralPrograma de Pós-graduação em Ciências da Saúde, Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.
Anne-Mieke VandammeDepartment of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium.
Johan Van WeyenberghDepartment of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium.
Ricardo KhouriPrograma de Pós-graduação em Ciências da Saúde, Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Brazil.
Fundação Oswaldo Cruz · BRUniversidade Federal da Bahia · BREscola Bahiana de Medicina e Saúde Pública · BRRega Institute for Medical Research · BEUniversidade Federal do Piauí · BRCentro de Biología Molecular Severo Ochoa · ESUniversidad Autónoma de Madrid · ESUniversity College London · GB

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214
6 · The paper itself

Abstract

Visceral leishmaniasis is an opportunistic disease in HIV-1 infected individuals, unrecognized as a determining factor for AIDS diagnosis. The growing geographical overlap of HIV-1 and

Indexed as

HIV-1hostpathogen interactionimmune activationLeishmania infantumvisceral leishmaniasis

Identifiers

PMID37601355
PMCPMC10436095
OpenAlexW4384826452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.